Partners: Partnering Strategy

Arcion is exploring its options related to partnerships for the further development and commercialization of ARC-4558, while the Company continues to make clinical progress with the candidate for the treatment of painful diabetic neuropathy.

All Business Development inquiries should be addressed to:

Kerrie Brady
Chief Business Officer
Arcion Therapeutics, Inc.
2400 Boston St, Suite 330
Baltimore, MD 21224
(410) 522-8701 x1184
kbrady@arciontherapeutics.com

"A key component of Arcion's corporate strategy is to seek out quality partnerships and collaborations."